Pharmaceutical

Eli Lilly to invest $4.5bn for drug manufacturing and trial medicine production

Eli Lilly has announced a $4.5bn investment to establish the Lilly Medicine Foundry for drug production and manufacturing medicines for clinical trials.

Oct 4, 2024 - 04:00
Eli Lilly to invest $4.5bn for drug manufacturing and trial medicine production
Eli Lilly has announced a $4.5bn investment to establish the Lilly Medicine Foundry for drug production and manufacturing medicines for clinical trials.
Read the original article

Tags:

Previous Article

Gilead signs agreements to facilitate access to HIV prevention drug

Next Article

Social media algorithms are driving the GLP-1 drugs boom

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Risk adjusted net present value: What is the current va...

Jul 2, 2024

Valneva wins FDA approval for the first chikungunya vaccine

Valneva wins FDA approval for the first chikungunya vac...

Nov 12, 2023

Risk adjusted net present value: What is the current va...

Dec 15, 2024